Inhibition of HB-EGF significantly diminished carcinoma cell growth in co-cultures with CAF from all eight hormone receptor negative (ER negative or PR negative) carcinomas but only in 44% of co-cultures with CAF from hormone receptor positive (ER and PR positive) tumors (P = 0.0095; Table S3). This evidence concerns the gene HBEGF and carcinoma.